Trevarx Biomedical, Inc. Company Profile, Contacts & Intelligence
Trevarx Biomedical, Inc. Overview
Trevarx develops small molecule radiopharmaceutical platforms focusing on oncology. Its first platform is a PARP inhibitor (PARPi) analogue with an α-emitting radioligand therapy [211At]PTT (currently in pre-clinical stage) with published proof of concept in neuroblastoma seeking additional indications in adult PARP-1 tumors. Trevarx's PARPi platform has a companion PET biomarker [18F]FTT (entering Phase 2 Multi-Center trials in breast cancer in Spring 2022, led by MD Anderson Cancer Center).
- Headquarters
- 3675 Market St
- Website
- www.trevarx.com
- Industry
- Biotechnology Research
- Founded
- 2016
- NAICS
- Research and Development in Biotechnology (except Nanobiotechnology)
Trevarx Biomedical, Inc. Contact Intelligence
See which contact channels and departments are represented in the visible AeroLeads data.
Trevarx Biomedical, Inc. People & Org Chart Preview
Sample people records show job titles and whether email or phone data is available without exposing raw contact details.
Compare Similar Companies to Trevarx Biomedical, Inc.
Explore companies in related markets and compare their industry and employee estimates.
| Company | Industry / match | Employee estimate | Page |
|---|---|---|---|
| Aro Biotherapeutics | Biotechnology | 52 | View company |
| NUCLIDIUM AG | Biotechnology Research | 20 | View company |
| Bound Therapeutics | Biotechnology Research | 6 | View company |
| Higher Medicine | Biotechnology Research | 5 | View company |
| BioLattice | Biotechnology Research | 3 | View company |
| Cerespectus™ | Medical Equipment Manufacturing | 3 | View company |
| DRS.LINQ | Medical Equipment Manufacturing | 3 | View company |
| QuneUp® | Software Development | 1 | View company |
| Ajaya Bio | Biotechnology Research | Not listed | View company |
| Valfard Therapeutics | Biotechnology Research | Not listed | View company |